Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q1 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q1 2027 | 1 | $0.56 | $0.56 | $0.56 |
| Q2 2027 | 1 | $0.55 | $0.55 | $0.55 |
| Q3 2027 | 1 | $0.54 | $0.54 | $0.54 |
| Q4 2027 | 1 | $0.60 | $0.60 | $0.60 |
| Q1 2028 | 1 | $1.77 | $1.77 | $1.77 |
| Q2 2028 | 1 | $1.73 | $1.73 | $1.73 |
| Q3 2028 | 1 | $1.69 | $1.69 | $1.69 |
| Q4 2028 | 1 | $1.88 | $1.88 | $1.88 |
Tevogen Bio Holdings Inc. last posted its earnings results on Friday, November 14th, 2025. The company reported $-0.03 earnings per share for the quarter, topping analysts' consensus estimates of $-0.0608 by $0.0308. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Tevogen Bio Holdings Inc. has generated $0 earnings per share over the last year ($-0.0936 diluted earnings per share) and currently has a price-to-earnings ratio of -2.53. Tevogen Bio Holdings Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 14th, 2025 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2025 | Q3 2025 | -$0.06 | -$0.03 | 0.03 | $0 | $0 |
| 08/14/2025 | Q2 2025 | N/A | -$0.03 | N/A | $0 | $0 |
| 05/14/2025 | Q1 2025 | -$0.05 | -$0.07 | -0.02 | $0 | $0 |
| 04/02/2025 | Q4 2024 | -$0.03 | -$0.05 | -0.02 | $396.59 K | $0 |
| 11/19/2024 | Q3 2024 | N/A | -$0.03 | N/A | N/A | $0 |
| 08/14/2024 | Q2 2024 | N/A | -$0.04 | N/A | $0 | $0 |
| 03/30/2024 | Q1 2024 | N/A | $0.08 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$0.01 | N/A | N/A | $0 |
| 09/28/2023 | Q3 2023 | N/A | -$0.02 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.16 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.26 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | $0.05 | N/A | N/A | $0 |
| 09/28/2022 | Q3 2022 | N/A | $0.03 | N/A | N/A | $0 |
| 06/28/2022 | Q2 2022 | N/A | $0.00 | N/A | N/A | $0 |
| 03/29/2022 | Q1 2022 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/29/2021 | Q4 2021 | N/A | -$0.00 | N/A | N/A | $0 |
| 09/28/2021 | Q3 2021 | N/A | -$0.00 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$0.00 | N/A | N/A | $0 |
Tevogen Bio Holdings Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 14th, 2025 based offlast year's report dates.
In the previous quarter, Tevogen Bio Holdings Inc. (:TVGN) reported $-0.03 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.0608 by $0.0308.
The conference call for Tevogen Bio Holdings Inc.'s latest earnings report can be listened to online.
The conference call transcript for Tevogen Bio Holdings Inc.'s latest earnings report can be read online.
Tevogen Bio Holdings Inc. (:TVGN) has a recorded net income of $-10,114,380.Tevogen Bio Holdings Inc. has generated $-0.0936 earnings per share over the last four quarters.
Tevogen Bio Holdings Inc. (:TVGN) has a price-to-earnings ratio of -2.53 and price/earnings-to-growth ratio is -0.03.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED